J Biol Chem, Vol. 274, Issue 36, 25550-25554, September 3, 1999
Additive Effects of
Chain Mutations in Low Oxygen
Affinity Hemoglobin
F41Y,K66T*
Véronique
Baudin-Creuza
,
Corinne
Vasseur-Godbillon,
Nathalie
Griffon,
Jean
Kister,
Laurent
Kiger,
Claude
Poyart,
Michael C.
Marden, and
Josée
Pagnier
From INSERM, Unité 473, 84 rue du Général
Leclerc, 94276 Le Kremlin-Bicêtre Cedex, France
 |
ABSTRACT |
In order to decrease significantly the oxygen
affinity of human hemoglobin, we have associated the mutation
F41Y
with another point mutation also known to decrease the oxygen affinity
of Hb. We have synthesized a recombinant Hb (rHb) with two mutations in
the
chains: rHb
F41Y,K66T. In the absence of
2,3-diphosphoglycerate, additive effects of the mutations are evident,
since the doubly mutated Hb exhibits a larger decrease in oxygen
affinity than for the individual single mutations. In the presence of
2,3-diphosphoglycerate, the second mutation did not significantly
increase the P50 value relative to the single
mutations. However, the kinetics of CO binding still indicate combined
effects on the allosteric equilibrium, as evidenced by more of the slow
bimolecular phase characteristic of binding to the deoxy conformation.
Dimer-tetramer equilibrium studies indicate an increase in stability of
the mutants relative to rHb A; the double mutant rHb
F41Y,K66T at pH
7.5 showed a K4,2 value of 0.26 µM. Despite the lower oxygen affinity, the single mutant
F41Y and double mutant
F41Y,K66T show only a moderate increase of
20% in the autoxidation rate. These mutations are thus of interest in
developing a Hb-based blood substitute.
 |
INTRODUCTION |
The search for human hemoglobin (Hb) variants exhibiting a low
oxygen affinity without requiring 2,3-diphosphoglycerate
(2,3-DPG)1 is of interest in
the view of producing a blood substitute. With this objective, we have
previously synthesized the recombinant Hb (rHb)
F41Y using the
genetic engineering approach (1). The naturally occurring mutated Hb
F41Y, first described by Burkert et al. (2), is known as
Hb Mequon. The mutation
F41Y occurs in an important region of the
subunit interface, which undergoes large rearrangements in the
transition between the deoxy (T state) and the liganded (R state)
conformations (3). We have shown that the recombinant Hb
F41Y
exhibits a lower oxygen affinity than Hb A, with a well preserved
cooperativity of oxygen binding and without increasing the rate of
autoxidation. The decreased oxygen affinity of rHb
F41Y is
attributed mainly to an increase in the allosteric constant,
L0 = T0/R0, because the oxygen
equilibrium dissociation constants for the T and R states,
KT and KR respectively, were not modified (1).
Based on the crystallographic structure of Hb A (4), it appears that
there could be an additional hydrogen bond in the deoxy conformation
between a tyrosyl residue at the
41(C7) site and the carbonyl of the
97(FG4) His residue within the same
chain. Such an interaction,
coupled with the native interchain hydrogen bond between the
Tyr-
242(C7) and Asp-
199(G1) residues, would help stabilize the deoxy state of rHb
F41Y.
In addition to the amino acids involved in the
1
2 interface, other key residues are
important in the cooperative ligand binding to human Hb. Specifically,
the amino acids implicated in the heme contact have a crucial role. The
study of naturally occurring human mutants has also confirmed the
importance of these regions. Indeed, over 600 natural variants of Hb
have been described (5), providing information about the role of
certain residues in the structural changes between the deoxy and oxy
conformations. Among these natural mutants, 54 displayed a decreased
oxygen affinity, with 7 and 47 for the
and
subunits,
respectively. In particular, Hb Chico (
K66T) with a mutation close
to the heme group exhibits a low oxygen affinity and a slight
instability (6). In deoxy Hb A, the residue Lys-
66 (E10) forms a
salt bridge with the carboxyl group of one propionic acid of the
-chain heme; this contact does not exist in the liganded form (4).
X-ray analysis of Hb Chico has shown that Thr-
66 may form a hydrogen
bond with His-
63 via a bridging water molecule. This introduces
additional steric hindrance to ligand binding to the T state (7).
With a view to study the combined effects of the mutations F41Y and
K66T in the same
subunit, we have produced an artificial human Hb
F41Y,K66T. We report here the functional properties of the double
mutant compared with those of native Hb A and the singly mutated Hbs.
 |
MATERIALS AND METHODS |
The Lys-
66
Thr mutation was introduced by site-directed
mutagenesis into the
-globin cDNA containing the code for the mutation Phe-
41
Tyr. The doubly mutated
globin was produced as a fusion protein in Escherichia coli using the expression
vector pATprTet-cII-FX-
Gb. After purification and cleavage of the
fusion protein by digestion with bovine activated coagulation factor X,
the
2
2 tetramer was reconstituted in the
presence of cyanohemin and native carbonmonoxy
subunits (8, 9). The
structure of the mutated chain was checked by reversed-phase high
performance liquid chromatography of tryptic digest and amino acid
analysis of the two mutated peptides. The purity of the rHb was
controlled by isoelectric focusing electrophoresis with a pH gradient
ranging from 6.0 to 8.0. The heat stability was tested by incubating
rHb
F41Y,K66T and Hb A (100 µM on a heme basis) at
65 °C in 10 mM phosphate buffer, pH 7.0 (10).
The tetramer-dimer equilibrium was studied by gel filtration on a
Superose 12 HR 10/30 column (Amersham Pharmacia Biotech, Uppsala,
Sweden) as described by Manning et al. (11). All experiments were performed at 25 °C, in 150 mM Tris acetate buffer,
pH 7.5. For concentrations of Hb ranging from 2 to 500 µM
on a heme basis, 10-µl aliquots were applied and eluted at a flow
rate of 0.4 ml/min. The absorbance of the eluent was measured at 415 and 280 nm. Diaspirin cross-linked (DLC) Hb was used as a control for
undissociable tetrameric Hb, and the peak position of the dimer was
determined using the dimeric natural mutant Hb Rothschild (12).
The rate of oxidation for liganded Hb samples was measured by
absorption spectrophotometry (SLM-Aminco DW2000) at 37 °C for samples under 1 atm of oxygen or under air (13). Hb solutions were 40 µM in heme in 20 mM potassium phosphate at pH
7.0.
Oxygen equilibrium curves were recorded with a continuous method using
the Hemox Analyzer system (TCS, Huntington Valley, PA) (14). The amount
of metHb calculated from the visible absorption spectra was found to be
less than 5% at the end of the recordings.
Fluorescence studies were performed on 10 µM Hb solutions
(on a heme basis) in 10 mM phosphate buffer, pH 7.0, using
an SLM 8000 spectrofluorometer. Emission spectra were recorded for both the buffer and the liganded Hb samples.
Kinetics of CO or oxygen recombination were obtained after flash
photolysis using 10-ns YAG laser pulses (Quantel, France) providing 160 mJ at 532 nm. Samples were in 1-mm cuvettes, with observation at 436 nm
(15). Measurements were made at 25 °C, 50 mM bis-Tris at
pH 7.0, 100 mM NaCl, for samples equilibrated under air or
1 or 0.1 atm of CO. Kinetics were recorded at different laser energies
to probe the Hb tetramer at different ligand saturation levels.
The CO dissociation rate was determined from the kinetics of
replacement of CO by NO, with measurements of full spectra
versus time using a diode array spectrophotometer (HP 8453).
Kinetics of O2 replacement by CO were measured with a
stopped-flow apparatus (Biologic, France) with detection at 420 nm. Experimental conditions were 50 mM bis-Tris at pH 7.0, 100 mM NaCl, at 25 °C. The dead time of this apparatus with
a cuvette of 1-cm optical path length is 2 ms. Hb samples equilibrated
under 1 atm of oxygen were mixed with a solution equilibrated under 1 atm of CO containing the oxygen scavenger sodium dithionite. The final
concentrations after mixing were 5 µM in heme, 5 mM sodium dithionite, 0.6 mM O2,
and 0.5 mM CO.
 |
RESULTS |
Properties of rHb
F41Y,K66T--
Analysis of the purified rHb
F41Y,K66T by isoelectric focusing showed that it migrated as a
single band (pI = 6.4), with a more cathodic position relative to
Hb A (pI = 6.98). Fluorescence studies did not show significant
differences between the doubly mutated rHb and native Hb A; the highly
quenched emission indicates a correctly reconstituted (folded) rHb. The
UV and visible absorption spectra of rHb
F41Y,K66T in carboxylated
and oxygenated forms were identical to those of native Hb A. Notably,
the ratios of absorbance intensity between the Soret band and UV peak
at 280 nm were normal, 4.87 and 3.5 for the mutated HbCO and
HbO2, respectively. The oxy form of rHb
F41Y,K66T
exhibited the same fraction denaturation as Hb A after a 20-min
incubation at 65 °C.
Tetramer-Dimer Equilibrium--
Hb A, rHb A, rHb
F41Y, and rHb
F41Y,K66T in the liganded form were eluted as a single peak whose
position varied between tetrameric and dimeric forms when the Hb
concentrations were in the range of the dissociation constant
K4,2 value. The K4,2
value for rHb A was 2-fold higher than that for natural Hb A, in
agreement with studies by Fronticelli et al. (16); at high
protein concentrations (favoring Hb tetramers), the functional
properties of Hb A and rHb A are similar as described previously (17,
18). The K4,2 values for rHb
F41Y and rHb
F41Y,K66T were 3- and 6-fold decreased, respectively, compared with
that for control rHb A (Table I).
View this table:
[in this window]
[in a new window]
|
Table I
Tetramer-dimer dissociation constants K4,2 for the liganded
form of Hb A, rHb A, rHb F41Y, and rHb F41Y,K66T
The dissociation constants K4,2 were determined by
the Hb concentration dependence of peak positions on a Superose-12
HR10/30 column. 10 µl of a Hb solution (2-500 µM on a
heme basis) were injected and eluted at a flow rate of 0.4 ml/min.
Experiments were performed at 25 °C in Tris acetate buffer, pH 7.5.
|
|
Autoxidation--
At 37 °C, the oxidation rate of rHb
F41Y,K66T under 1 atm of oxygen was increased by 20% compared with
that of native Hb A. Under air, the rHb
F41Y,K66T, which is less
oxygen-saturated than Hb A, exhibited a 2-fold increase in oxidation
rate relative to Hb A.
Oxygen Equilibrium Curves--
Fig.
1 shows the experimental Hill plots
obtained for Hb A, rHb
F41Y, and rHb
F41Y,K66T in the absence
(Fig. 1A) or in the presence of chloride anions (Fig.
1B). Table II displays the
values of the oxygen binding parameters for Hb A, the natural Hb Chico (data of Bonaventura et al. (7)), rHb
F41Y (1), and the double mutant rHb
F41Y,K66T in the presence and in the absence of
chloride anions.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 1.
Oxygen equilibrium curves for Hb A
(1), rHb F41Y
(2), and rHb F41Y,K66T
(3) in the absence (A) and in the
presence (B) of 100 mM NaCl.
|
|
View this table:
[in this window]
[in a new window]
|
Table II
Oxygen binding parameters for Hb A, rHb F41Y, Hb Chico, and rHb
F41Y,K66T
The P50 (mm Hg) and n50 values
were calculated by linear regression from the Hill equation for oxygen
saturation levels between 40 and 60%. log P50
expresses the shift in P50 for the mutant relative
to Hb A. Experimental conditions were as follows: 0.1 M
NaCl, 0.05 M bis-Tris or Tris buffer, pH 7.2, 50 µM EDTA, 20 µg/ml catalase, 60-80 µM
heme, 25 °C.
|
|
In the absence of chloride, the oxygen affinity of the rHb
F41Y,K66T
was decreased 2.5-fold relative to that of control Hb A and by about
1.5-fold relative to that of rHb
F41Y. The shift in log
P50 was 0.34 for Hb Chico, 0.18 for rHb
F41Y,
and 0.42 for the double mutant rHb
F41Y,K66T, thus showing a partial
additivity of the two mutations (
log P50 = 0.52 for a maximal additivity effect). The Hill coefficient at
half-saturation (n50), an index of oxygen
binding cooperativity, was more decreased for rHb
F41Y,K66T than for
rHb
F41Y.
In the presence of chloride, the double mutant rHb
F41Y,K66T still
exhibited an oxygen affinity lower than Hb A, Hb Chico, and rHb
F41Y. Nevertheless, the
log P50 for rHb
F41Y,K66T was equal to 0.45 (0.32 in the presence of 2,3-DPG). This
indicates that the effects of the two mutations were no longer additive in the presence of effectors. The values of
log
P50 corresponding to the oxygen-linked
heterotropic allosteric effectors showed that the chloride, 2,3-DPG and
alkaline Bohr effects were in the normal range of values (Table
III).
View this table:
[in this window]
[in a new window]
|
Table III
Heterotropic effects log (P50) in Hb A, rHb
F41Y, and rHb F41Y,K66T
The experimental conditions are described in the legend of Table II.
|
|
From the experimental curves (Fig. 1), the allosteric parameters were
fitted to the equation of the two-state allosteric model (19) to obtain
the oxygen dissociation constants KT and
KR for the T and R states, respectively (Table
IV).
View this table:
[in this window]
[in a new window]
|
Table IV
Allosteric parameters for Hb A, rHb F41Y, and rHb F41Y,K66T
The allosteric parameters (L, KR, and
KT) were obtained after fitting the experimental
curves to the equation of the two-state allosteric model (19) by using
a nonlinear least-squares procedure. KR and
KT (mm Hg) are the oxygen dissociation constants for
the R and T states, respectively; L is the allosteric
constant (T0/R0);
c = KR/KT; the
switchover point is was calculated as -log
L/log c; % T3 is the amount of triply liganded T
state species calculated as (Lc3)/(1 + Lc3). The standard error per point was typically
0.003-0.006.
|
|
In all experimental conditions, the equilibrium curves could be
simulated with values of KT and
KR for rHb
F41Y,K66T and rHb
F41Y, similar
to those for Hb A, indicating that the mechanism of the low oxygen
affinity was mainly due to the change in the allosteric equilibrium.
The allosteric parameter L was higher for rHb
F41Y,K66T than for Hb
A and rHb
F41Y. The switchover point indicates that the allosteric
transition T
R for rHb
F41Y,K66T occurs at a higher oxygen
saturation level than for Hb A and rHb
F41Y. The calculated amount
of rHb
F41Y,K66T in the T state for tetramers with three ligands was
considerably increased: 85% versus 38 and 16% for rHb
F41Y and Hb A, respectively. This large increase in the fraction of
T state is due to the presence of the mutation
K66T.
Kinetic Studies--
Fig. 2 shows
the recombination traces of CO after photodissociation. For rHb
F41Y,K66T as for Hb A, the traces were biphasic as expected for
tetrameric Hb. At low CO photodissociation levels (5%), the CO
recombination kinetics of Hb A were fast and monophasic because in
these conditions the majority of the photodissociated tetramers are
triliganded and remain in the R state. In the same conditions, the CO
recombination kinetics of rHb
F41Y,K66T still exhibited some slow
phase. These results show, as for the oxygen equilibrium curves, that
the allosteric equilibrium of partially liganded species of rHb
F41Y,K66T are displaced toward the T state relative to Hb A.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 2.
Kinetics of CO recombination to Hb A and
rHb F41Y,K66T. Relative to either single
mutant, the double mutant shows more of the slow phase, characteristic
of CO binding to the deoxy conformation. This demonstrates an additive
effect of the two mutations. The addition of inositol hexaphosphate
(IHP) provides an additive effect of further increasing the
slow fraction as well as a decrease in the rate of the slow phase;
while less evident from oxygen equilibrium data, the mutations also
show an additive effect with the external effectors.
|
|
The oxygen association and dissociation rates for Hb A and rHb
F41Y,K66T were similar (Table V).
These results are consistent with the equilibrium data that show that
the value of KR for rHb
F41Y,K66T was similar
to that of Hb A. However, the CO kinetics suggest a change in the R
state properties as well as the shift in allosteric equilibrium.
View this table:
[in this window]
[in a new window]
|
Table V
Kinetics of CO and oxygen bimolecular recombination to Hb A and rHb
F41Y,K66T
Association rates were measured by the flash photolysis method. Oxygen
and CO dissociation rates for fully liganded Hb were determined by
replacement with CO and NO, respectively. Hb samples were in 50 mM bis-Tris, 100 mM NaCl, 20 °C, pH 7.0.
|
|
 |
DISCUSSION |
In order to obtain a modified Hb that could be used as a Hb-based
artificial oxygen carrier, we have used two different strategies to
decrease the oxygen affinity of human Hb. We first introduced a
mutation in the allosteric interface (
F41Y) to shift the equilibrium toward the T state by inducing an additional hydrogen bond in the T
state conformation, without perturbing the R state conformation. To
further decrease the oxygen affinity, we have then investigated the
association of this mutation with a second substitution known to have a
similar effect, but due to another mode of action.
In normal human Hb, the Phe-
41 belongs to a cluster of three highly
conserved phenylalanine residues,
41(C7),
42(CD1), and
45(CD4), that participate in the formation of the hydrophobic heme
pocket; in Hb A, the Phe-
41 has contacts with the heme moiety and is
critical to the structural integrity and function of the Hb molecule.
Decreased oxygen affinity was observed for the naturally mutated Hb
Denver Phe-
41
Ser (20) and Hb Bruxelles deletion of Phe-
41
(21). Hb Denver is an unstable Hb variant; the smaller serine residue
may impede movement during the allosteric transition of the FG corner
of the
subunits along the C helix of the subunits (20). The mutated
Hb corresponding to naturally occurring Hb Mequon (2) was synthesized
after site-directed mutagenesis to study the functional properties of
the pure form (1). The working hypothesis of the
F41Y mutation was
to induce an additional hydrogen bond in the T state conformation
without perturbing the R state conformation. If the
41 tyrosyl
residue forms a new hydrogen bond to the carbonyl of the
97 (FG4)
histidine residue within the same
chain, then the deoxy
conformation may be stabilized. While the oxidation rate and heat
stability are similar to those of Hb A, this Hb exhibited a 2-fold
decrease in oxygen affinity compared with that of Hb A, due to a shift
in the allosteric equilibrium.
When two effects have an independent mode of action, the combined
effects may be additive. In general, a partial additivity is observed,
as shown for the free energy of dimer-tetramer equilibrium for Hb
mutants (22). We thus associated the
F41Y mutation with a
substitution of a residue on the distal side of the heme (
K66T) to
directly act on the heme environment. The abnormal Hb Chico, Lys-
66
Thr, displays a significantly decreased O2 affinity (6,
7). The
66 residue is not involved in the subunit interface and is
not expected to have a direct effect on the subunit dissociation. x-ray
analysis of the deoxy conformation of Hb A shows that Lys-
66 makes
an ionic bond (salt bridge) between its
amino group and the
carboxyl group of propionate-7 of the heme (4). The disruption of the
ionic bond provided by Lys was first suspected to be the cause of the
altered O2 binding. Other single amino acid substitutions have been investigated to date by site-directed mutagenic protein engineering, Lys-
66
Ser and Lys-
66
Arg, that lead also to decreased O2 oxygen affinity (23), while the natural mutant Hb I-Toulouse, Lys-
66
Glu (24, 25), and the engineered Hb
Lys-
66
Gly (26) have been reported to have normal oxygen binding
function. These substitutions also eliminate the ionic bond; thus, the
rupture of the bridge involving the Lys-
66 would not be the cause of
the low oxygen affinity of Hb Chico. The fact that the monomeric as
well as the tetrameric
chains of Hb Chico also show a decreased
oxygen affinity suggests a tertiary effect (7).
Hb tetramers dissociate reversibly into 
dimers, involving the
breaking of certain bonds at the
1
2 and
2
1 interfaces. The tetramer dissociation
constant (K4,2 = [dimer]2/[tetramer]) is on the order of 1 µM for liganded Hb A, while the deoxy (T state) tetramers
are much more stable (27). The literature values vary greatly for this
parameter. This is in part due to the influence on the solvent
conditions; e.g. K4,2 is about 0.2 µM at low ionic force but increases to 1 µM
at 100 mM NaCl. Protein folding may also play an important
role, since the values reported for rHb are often twice that of native
Hb A.
For mutant Hbs, the value of the tetramer dissociation constant may be
a useful probe of the stability of the protein (11, 22). In addition to
an altered oxygen affinity, Hb Chico Lys-
66
Thr shows an
increase in the fraction dimer and in the autoxidation rate (6, 7).
However, we observed a decrease in the K4,2 value for the association of both mutations F41Y and K66T. The K4,2 value for liganded rHb
F41Y is decreased
3-fold compared with that of rHb A (Table I), and an additional
decrease of a factor of 2 was observed for the double mutant.
Quantification of the additivity requires a choice of parameters. The
P50 value is one obvious choice for its
simplicity and reliability of measurement; however, it depends on
several microscopic parameters that determine the intrinsic affinity
and allosteric equilibrium. An increase due to the allosteric
transition could be compensated by a decrease in
KT or an increase in the fraction dimers. In the
absence of external effectors, the rHb
F41Y,K66T exhibits a lower
oxygen affinity than for either single mutation; the effects of the
mutations are additive. For Hb A, the distance between the residues
41 and
66 is 15.4 and 17 Å for the T state and R state,
respectively. The two residues have no direct contact, as illustrated
in Fig. 3, and in principle do not have a
correlated participation in their effects on the oxygen affinity. The
partial additivity of their effects on the intrinsic oxygen affinity of rHb
F41Y,K66T is therefore probably due to two independent
mechanisms. One can also consider the combined effects of the mutations
with the effectors such as 2,3-DPG or inositol hexaphosphate; with 2,3-DPG or inositol hexaphosphate, the additivity is less pronounced (Fig. 2). This does not imply that the two effects are no longer additive but rather that the change in P50 may
no longer have the same magnitude. The flash photolysis kinetics are
sometimes more sensitive to changes in the allosteric equilibrium for a late switchover point, e.g. when the transition from T to R
occurs only after binding the third ligand. Low photodissociation
levels can isolate the reaction for binding the fourth ligand.

View larger version (67K):
[in this window]
[in a new window]
|
Fig. 3.
Three-dimensional structure of Hb A in the R
state showing the sites Phe- 41 (in
white) and Lys- 66 (in
blue). The image was obtained using the VISP
program (de Castro and Edelstein, University of Geneva, Switzerland)
with a Silicon Graphics 4D25G workstation. The Hb A crystallographic
coordinates were taken from the file 1HHO (Protein Data Bank, Research
Collaboratory for Structural Bioinformatics, Rutgers University, New
Brunswick, NJ) for the oxygenated quaternary structure.
|
|
The ligand binding properties of this new rHb demonstrate that several
mutations may be introduced to obtain combined effects on the oxygen
affinity. This would eliminate the need for an external effector, such
as 2,3-DPG, as required for a Hb-based blood substitute. However, lower
oxygen affinities are often accompanied by an increased autoxidation
rate. Unless these parameters can be decoupled, one must accept a
compromise of the best oxygen affinity and lowest autoxidation rate
(28). The present results show that Hb can be genetically engineered to
regulate the oxygen affinity. By associating several smaller changes,
the perturbations in the protein stability can be minimized. This
appears to be the case for the present study of two mutations in the Hb
chains, one inducing a shift in the allosteric equilibrium (
41
mutation) and the other inducing a decrease in the intrinsic oxygen
affinity (
66 mutation). There is no conflict in accommodating both
changes, and an overall additive effect is observed.
 |
ACKNOWLEDGEMENTS |
We thank G. Caron, E. Domingues, and V. Jonval for skillful technical assistance. We are grateful to Dr. H. Wajcman for the gift of a sample of Hb Rothschild, and to the Baxter
Healthcare Company for DCL Hb.
 |
FOOTNOTES |
*
This research was supported by the Institut National de la
Santé et de la Recherche Médicale, the Direction de la
Recherche et de la Technologie (contract 92/177), and the Faculté
de Médecine Paris Sud.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.:
33-1-46-70-89-89; Fax: 33-1-46-70-64-46; E-mail:
baudin@kb.inserm.fr.
 |
ABBREVIATIONS |
The abbreviations used are:
2,3-DPG, 2,3-diphosphoglycerate;
rHb, recombinant Hb.
 |
REFERENCES |
| 1.
|
Baudin, V.,
Pagnier, J.,
Lacaze, N.,
Bihoreau, M-T.,
Kister, J.,
Marden, M. C.,
Kiger, L.,
and Poyart, C.
(1992)
Biochim. Biophys. Acta
1159,
223-226[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Burkert, L. B.,
Sharma, V. S.,
Pisciotta, A. V.,
Ranney, H. M.,
and Bruckheimer, S.
(1976)
Blood
48,
645-651[Abstract/Free Full Text]
|
| 3.
|
Perutz, M. F.
(1970)
Nature
228,
726-739[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Fermi, G.,
Perutz, M. F.,
Shaanan, B.,
and Fourme, R.
(1984)
J. Mol. Biol.
175,
159-174[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Hardison, R.,
Chui, D. H. K.,
Riemer, C.,
Miller, W.,
Carver, M.,
Molchanova, T.,
Efremov, G.,
and Huisman, T. H. I.
(1998)
Hemoglobin
22,
113-127[Medline]
[Order article via Infotrieve]
|
| 6.
|
Shih, D.,
Jones, R. T.,
Shih, M. F. C.,
Jones, M. B.,
Koler, R. D.,
and Howard, J.
(1987)
Hemoglobin
11,
453-464[Medline]
[Order article via Infotrieve]
|
| 7.
|
Bonaventura, C.,
Cashon, R.,
Bonaventura, J.,
Perutz, M. F.,
Fermi, G.,
and Shih, D. T.
(1991)
J. Biol. Chem.
266,
23033-23040[Abstract/Free Full Text]
|
| 8.
|
Nagai, K.,
and Thogersen, H. C.
(1987)
Methods Enzymol.
153,
461-481[Medline]
[Order article via Infotrieve]
|
| 9.
|
Bihoreau, M. T.,
Baudin, V.,
Marden, M.,
Lacaze, N.,
Bohn, B.,
Kister, J.,
Schaad, O.,
Dumoulin, A.,
Edelstein, S. J.,
Poyart, C.,
and Pagnier, J.
(1992)
Protein Sci.
1,
145-150[Abstract]
|
| 10.
|
Wajcman, H.,
Elion, J.,
and Labie, D.
(1973)
Nouv. Rev. Fr. Hématol.
13,
89
|
| 11.
|
Manning, L. R.,
Jenkins, W. T.,
Hess, J. R.,
Vandegriff, K.,
Winslow, R. M.,
and Manning, J. M.
(1996)
Protein Sci.
5,
775-781[Abstract]
|
| 12.
|
Gacon, G.,
Belkhodja, O.,
Wajcman, H.,
and Labie, D.
(1977)
FEBS Lett.
82,
243-246[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Griffon, N.,
Baudin, V.,
Dieryck, W.,
Dumoulin, A.,
Pagnier, J.,
Poyart, C.,
and Marden, M. C.
(1998)
Protein Sci.
7,
673-680[Abstract]
|
| 14.
|
Kister, J.,
Poyart, C.,
and Edelstein, S. J.
(1987)
J. Biol. Chem.
262,
12085-12091[Abstract/Free Full Text]
|
| 15.
|
Marden, M. C.,
Kister, J.,
Bohn, B.,
and Poyart, C.
(1988)
Biochemistry
27,
1659-1664[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Fronticelli, C.,
Gattoni, M.,
Lu, A. L.,
Brinigar, W. S.,
Bucci, J. L. G.,
and Chiancone, E.
(1994)
Biophys. Chem.
51,
53-57[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Nagai, K.,
Perutz, M. F.,
and Poyart, C.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
7252-7255[Abstract/Free Full Text]
|
| 18.
|
Kim, H. W.,
Shen, T. J.,
Sun, D. P.,
Ho, N. T.,
Madrid, M.,
and Ho, C.
(1995)
J. Mol. Biol.
248,
867-882[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Monod, J.,
Wyman, J.,
and Changeux, J. P.
(1965)
J. Mol. Biol.
12,
88-118[Medline]
[Order article via Infotrieve]
|
| 20.
|
Stabler, S. P.,
Jones, R. T.,
Head, C.,
Shih, D. T.,
and Fairbanks, V. F.
(1994)
Mayo Clin. Proc.
69,
237-243[Medline]
[Order article via Infotrieve]
|
| 21.
|
Griffon, N.,
Badens, C.,
Lena-Russo, D.,
Kister, J.,
Bardakjian, J.,
Wajcman, H.,
Marden, M. C.,
and Poyart, C.
(1996)
J. Biol. Chem.
271,
25916-25920[Abstract/Free Full Text]
|
| 22.
|
Turner, G. J.,
Galacteros, F.,
Doyle, M. L.,
Hedlund, B.,
Pettigrew, D. W.,
Turner, B. W.,
Smith, F. R.,
Winston, M-P.,
Rucknagel, D. L.,
and Ackers, G. K.
(1992)
Proteins
14,
330-350
|
| 23.
|
Kono, M.,
Miyazaki, G.,
Nakamura, H.,
Wada, Y.,
and Imai, K.
(1998)
Protein Eng.
11,
199-204[Abstract/Free Full Text]
|
| 24.
|
Rosa, J.,
Labie, D.,
Wajcman, H.,
Boigne, J. M.,
Cabannes, R.,
Bierme, R.,
and Ruffie, J.
(1969)
Nature
223,
190-191[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Labie, D.,
Rosa, J.,
Belkhodja, O.,
and Bierme, R.
(1971)
Biochim. Biophys. Acta
236,
201-207[Medline]
[Order article via Infotrieve]
|
| 26.
|
Shih, D. T.,
Miyazaki, G.,
and Nagai, K.
(1987)
Fed. Proc.
46,
1972
|
| 27.
|
Thomas, J. O.,
and Edelstein, S. J.
(1973)
J. Biol. Chem.
248,
2901-2905[Abstract/Free Full Text]
|
| 28.
|
Marden, M. C.,
Griffon, N.,
and Poyart, C.
(1995)
Trans. Clin. Biol.
6,
473-480
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Dewilde, L. Kiger, T. Burmester, T. Hankeln, V. Baudin-Creuza, T. Aerts, M. C. Marden, R. Caubergs, and L. Moens
Biochemical Characterization and Ligand Binding Properties of Neuroglobin, a Novel Member of the Globin Family
J. Biol. Chem.,
October 12, 2001;
276(42):
38949 - 38955.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.